|Year : 2019 | Volume
| Issue : 6 | Page : 566-570
|Evaluate efficacy of desensitizing toothpaste containing zinc-carbonate hydroxyapatite nanocrystals: Non-comparative eight-week clinical study
Dhafer Al Asmari, Muhammad K Khan
Department of Periodontics and Oral Medicine, College of Dentistry, Qassim University, Buraidah, Kingdom Saudi Arabia
|Date of Submission||13-Jun-2019|
|Date of Acceptance||26-Sep-2019|
|Date of Web Publication||25-Oct-2019|
Dr. Muhammad K Khan
Department of Periodontics and Oral Medicine, College of Dentistry, Qassim University,
Kingdom Saudi Arabia
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Objective: The aim of the study was to evaluate the clinical effectiveness of desensitizing toothpaste in reducing the dentine hypersensitivity (DH). Materials and Methods: The study was a before and after clinical trial conducted to evaluate the clinical efficacy of a desensitizing toothpaste containing zinc-carbonate hydroxyapatite nanocrystals (Zn-CHA) for controlling DH. The trial involved 72 patients with DH who were evaluated four and eight weeks after using Zn-CHA toothpaste. The sensitivity was assessed by airblast method using Schiff Sensitivity Scale. Results: Repeated measures analysis of variance test was used to compare baseline score with fourth and eighth week. Statistically significant differences were observed between sensitivity scores at baseline and those at four- and eight-week intervals (P < 0.001). Conclusion: The results suggested that the use of Zn-CHA nanocrystals dentifrice might become an effective therapy to reduce DH.
Keywords: Biorepair sensitive toothpaste, clinical trial, dentine hypersensitivity, Schiff Sensitivity Scale, zinc-carbonate hydroxyapatite nanocrystals
|How to cite this article:|
Al Asmari D, Khan MK. Evaluate efficacy of desensitizing toothpaste containing zinc-carbonate hydroxyapatite nanocrystals: Non-comparative eight-week clinical study. J Int Soc Prevent Communit Dent 2019;9:566-70
|How to cite this URL:|
Al Asmari D, Khan MK. Evaluate efficacy of desensitizing toothpaste containing zinc-carbonate hydroxyapatite nanocrystals: Non-comparative eight-week clinical study. J Int Soc Prevent Communit Dent [serial online] 2019 [cited 2019 Dec 11];9:566-70. Available from: http://www.jispcd.org/text.asp?2019/9/6/566/269920
| Introduction|| |
Pain due to dentin hypersensitivity (DH) is an increasing problem in clinical dentistry, desensitizing dentifrices are the best and are commonly used in reducing and controlling DH. Many treatment modalities have been proposed for controlling DH, but still definite treatment is questionable.
The oral care companies in the world have manufactured many dentifrices for this common problem of DH. These treatment modalities have been used over the years, and particular attention has been focused on home care use of dentifrices containing compounds, blocking either the hydrodynamic mechanism or the neural response.
Enamel and dentin have no natural ability to heal when affected by caries, abrasions, erosion, or fractures because enamel contains no cells. When enamel and dentin are exposed in oral cavity, they can be rebuilt with the help of alloplastic materials that make artificial restoration. DH is diagnosed when stimuli such as fluids or cold air cause a short but severe pain, which arises from exposed dentin. The etiology of DH is multi‑factorial, with interactions between stimulus and predisposing factors causing its aggravation. The exposure time between the tooth and the acid was found to be a more important risk factor for DH when comparing frequency of dietary acid intake or frequency of toothbrushing.
Dentifrice containing 20% nano-sized carbonate apatite (n-CAP) was found most effective in occluding the dentinal tubules. Carbonate-hydroxyapatite nanocrystals (CHA) have been used for remineralization of the altered enamel surfaces. Remineralization produced by the use of carbonate-hydroxyapatite involves in a deposition of a new apatite mineral over the eroded enamel surface., CHA dentifrice was found to be very effective in reducing DH after four and eight weeks in a randomized controlled trial (RCT).
The acceptance of these dentifrices by both the professional and the lay public requires scientifically documented clinical efficacy. The purpose of this clinical study was to evaluate the effect of desensitizing toothpaste containing Zn-CHA nanocrystals in reducing or controlling DH after eight weeks of treatment by means of the participating subject’s response to the most common and validated stimuli test: airblast test Schiff Sensitivity Scale (SSS).
| Materials and Methods|| |
This was a before–after clinical study design; the same outcomes were measured during intervention/exposure in one group (uncontrolled). This was an eight-week single center, before and after use of desensitize dentifrice. This study was conducted in the College of Dentistry, Qassim University, Kingdom of Saudi Arabia, and was approved by a Dental Ethics Committee of Qassim University under the Code no.: ST/55/2019, and informed consent was sought from all patients. Universal Trial Number (UTN) #: U1111-1237-7624 obtained from World Health Organization and Clinical Trial ID #: NCT04091256 from ClinicalTrial.gov. For transparent and good quality, reporting of clinical trials guideline of consolidated standards of reporting trials (CONSORT) 2010 was followed in this study. Without transparent reporting, the reliability and validity of study are questionable. CONSORT 2010 was followed in the research protocol and methodology. A sample size of 72 subjects for the treatment of DH before and after using desensitizing toothpaste containing Zn-CHA nanocrystals would give 80% power to detect treatment change from baseline following four- and eight-week treatment as measured on the SSS scale. Samples (participants) included in this study were suffering from DH and fulfill the inclusion criteria.
All male and female subjects were 20–70 years of age in good health and having two teeth with DH; only incisors, canines, and premolars were included with the exposed cervical dentin (facial surfaces). All participants of the study having SSS score of 2 and 3 were included in this clinical evaluation of desensitizing toothpaste.
Subjects with deep carious teeth, defective restorations, any pathological lesion, periodontal disease, mobile teeth, cracked enamel, orthodontic appliances, and periodontal pockets >4mm were not included in the study. Subjects using pain control medicines, sensitive toothpaste, and pregnant or lactating women were excluded from the study.
At baseline, four trained examiners, with a Kappa score (0.83) for intra-examiner reliability, performed the clinical examination and recorded the data. Sensitivity was assessed by airblast sensitivity, using SSS described as follows:
0 = Subject does not respond to air stimulus
1 = Subject responds to air stimulus but does not request discontinuation of stimulus
2 = Subject responds to air stimulus and requests discontinuation or moves from stimulus
3 = Subject responds to air stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus
At baseline, all subjects were instructed to brush their teeth twice a day (Bass Technique) with Zn-CHA nanocrystals toothpaste (Biorepair, Coswell, Bologna, Italy) and a new toothbrush (Soft, Biorepair Curve soft toothbrush, COSWELL SPA Italy) for 1–2min.
All participants of the study were instructed to report after four weeks for first follow-up. At first follow-up, oral soft tissue examination was carried out in order to assess the safety of the products and to reevaluate the SSS at this stage. Participants were instructed for second follow-up after four weeks. At second follow-up, SSS was reevaluated along with soft tissue examination to assess the safety of the products.
IBM Statistical Package for the Social Sciences (SPSS) software, version 22 (IBM, Chicago, Illinois) was used for data analysis. Mean value ± standard deviation (SD) was calculated to present quantitative data such as age and SSS score. Frequency (%) was measured for categorical data such as gender. Repeated measures analysis of variance (ANOVA) test was applied; further, multiple comparisons were also performed, for that Bonferroni test was used to compare SSS score at baseline score, at fourth, and at eighth week. P value ≤ 0.05 was considered as significant.
| Results|| |
The average age of the 72 participants was 51.63 ± 9.65 (29–69) years. There were 40 (56%) males and 32 (44.4%) females. Proportion of males was higher than females. Of the total subjects, 27 (37.5%) subjects had age less than or equal to 50 years and 45 (62.5%) subjects had more than 50 years of age. Most of the study subjects were from >50 years of age group [Table 1].
Distribution of SSS score at baseline, at fourth, and at eighth week was presented, it showed that 24 (33.3%) subjects had SSS score of 2 and 48 (66.7%) subjects had SSS score of 3 at baseline [Table 2]. After four weeks, 3 (4.2%) subjects had SSS score 0, 44 (61.1%) had SSS score 1, and 25 (34.7%) had SSS score 2, whereas on the last follow-up after eight weeks of treatment, most of the subjects, that is, 48 (66.7%) had achieved improvement in controlling DH with SSS score 0, 23 (31.9%) subjects still had SSS score 1, whereas only 1 (1.4%) had SSS score 2 [Table 2].
|Table 2: Distribution of Schiff Sensitivity Scale score at baseline, fourth, and eighth week|
Click here to view
Correlation between different assessment times was computed pair wise, SSS score at baseline and at fourth week showed 0.56 (P = 0.001) correlation, which was moderately positive; SSS score at baseline and at eighth week showed 0.253 (P = 0.032) correlation, which was weak but positive; and SSS score at fourth and eighth week showed 0.677 (P = 0.001) correlation, which was also moderately positive; all pairs showed significant results with P < 0.05 [Table 3].
The mean SSS score at baseline was 2.67 ± 0.475, at fourth and at eighth week, the mean SSS score was 1.31 ± 0.547 and 0.35 ± 0.508, respectively. Repeated measures ANOVA test was applied to determine the statistical significance of the difference between baseline SSS score and those after four and eight weeks of treatment with toothpaste. As compared to baseline, after four and eight weeks, clinically SSS scores were reduced significantly (P = 0.001) [Table 4], [Figure 1]. Multiple comparisons also showed significant improvement in SSS score, improvement was statistically significant from baseline to eighth week with P = 0.001 [Table 5]., ,
| Discussion|| |
de Melo Alencar et al., in a systemic review, concluded that desensitizing dentifrices containing nano-hydroxyapatite (n-HAP) are effective for the relief of DH in both at-home and in-office treatments when compared with other desensitizing dentifrices.
Poggio et al. showed in an in vitro study that both toothpastes tested (Pronamel and Biorepair Plus) offered an amount of shield from erosive drinks, without statistical difference, but shielding effect was more apparent for Biorepair. Anand et al., in double blind RCT, evaluated the effects of nano-hydroxyapatite (n-HA) toothpaste compared with 8% arginine-containing toothpaste in the treatment of DH.
Orsini et al. conducted three-day study on three desensitizing dentifrices. They concluded that all tested desensitizing dentifrices reduced DH on a short-term basis, with a comparable level of overall efficacy and no adverse effects. Zn-CHA dentifrice was found to be clinically better due to rapid relief from DH. Anti-sensitivity dentifrice (ultralow abrasivity) containing 5% sodium tripolyphosphate was also found to be effective in reducing the extrinsic dental stains.
Ayad et al. concluded in a clinical study that a desensitizing dentifrice provides statistically significant reduction and control in DH when used as an adjunctive with daily home care hygiene procedures. Verma et al. used two different desensitizing agents, BisBlock, BISCO, Schaumburg, IL USA, an oxalate-containing desensitizer, and GLUMA, Kulzer South Bend, Indiana USA, a glutaraldehyde-containing desensitizer, in an RCT, and they found that BisBlock significantly reduced DH.
Alessandri Bonetti et al. concluded that the use of a Zn-CHA-containing toothpaste was found to be able to protect stripped enamel surfaces from demineralization in vitro. Use of fluoride in the form of toothpaste, gel, and varnishes was considered as the gold-standard method to reduce the incidence of demineralization and in the prevention of early lesions in the enamel.,
Dentifrices containing Zn-HAP lead to significant enamel remineralization of enamel showing that these toothpastes can be beneficial pertinent to enamel erosion.
New desensitizing toothpaste containing 15% n‑HA crystals and Remin Pro, VOCO Germany can provide effective tubule occlusion and reduce the pain and control DH.
Vano et al. in a double-blind RCT concluded that the use of n-HA in gel dentifrices is an effective desensitizing material that controls pain and reduces DH.
In our eight-week study, it was also concluded that dentifrice based on Zn-CHA nanocrystals is capable of remineralization and reducing or controlling DH. Drop in the SSS score was achieved using desensitizing toothpaste containing zinc-carbonate hydroxyapatite (Zn-CHA).
In this study, hypothesis was that Zn-CHA nanocrystals–containing toothpaste controlled DH. This study proved that using the Biorepair toothpaste containing Zn-CHA nanocrystals reduced the DH very well.
Limitation and recommendation: Adequate scientific literature for the support of product is not available. This was merely one group (uncontrolled) quasi-experimental single center study. Considering the results of this study, it is suggested that in future RCT design should be performed in multicenter for further clinical evaluation of this sensitive toothpaste.
| Conclusion|| |
The use of the desensitizing toothpaste containing Zn-CHA in patients with DH provides significant rapid relief from DH. Results appear clinically relevant as the toothpaste can be safely prescribed to patients with DH for home use. The toothpaste being fluoride free is also safe for younger children in case of ingestion.
Ethical policy and institutional review board statement
This study was approved by the dental ethics committee at Qassim University: Code #: ST/55/2019.
We would like to acknowledge Prof. Khalid Almas, Prof. Abdul Haleem, Prof. Asif Hanif, and Dr. Maryam Younus for their contribution in the preparation of the manuscript. We would also like to acknowledge Mr. Bashir Shakib Al Jabri, Dr. Ezzat Hamid Mabrouk, and Mr. Abdul Rahman Abdul Dam of Medical and Pharmaceutical Services, Kingdom of Saudi Arabia, for their extended help and for providing samples in this valuable study.
Financial support and sponsorship
This study was funded by Qassim University, Kingdom of Saudi Arabia.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Arnold WH, Prange M, Naumova EA Effectiveness of various toothpastes on dentine tubule occlusion. J Dent 2015;43:440-9.
Kopycka-Kedzierawski DT, Meyerowitz C, Litaker MS, Chonowski S, Heft MW, Gordan VV, et al
. National Dental PBRN Collaborative Group. Management of dentin hypersensitivity by national dental practice-based research network practitioners: Results from a questionnaire administered prior to initiation of a clinical study on this topic. BMC Oral Health 2017;17:41.
Yates R, Ferro R, Newcombe RG, Addy M A comparison of a reformulated potassium citrate desensitising toothpaste with the original proprietary product. J Dent 2005;33:19-25.
Veis A Materials science. A window on biomineralization. Science 2005;307:1419-20.
Rimondini L, Palazzo B, Iafisco M, Canegallo L, Demarosi F, Merlo M, et al
. The remineralizing effect of carbonate-hydroxyapatite nanocrystals on dentine. Materials Science Forum 2007;539: 602-5.
Rees JS, Addy M A cross-sectional study of buccal cervical sensitivity in UK general dental practice and a summary review of prevalence studies. Int J Dent Hyg 2004;2:64-9.
Chowdhary Z, Gupta P, Kaur J, Garg Y, Swarup N Multifaceted assessment of dentine hypersensitivity, evaluation of demographic prevalence along with associated factors: A cross-sectional study. J Indian Soc Periodontol 2019;23:64-8.
O'Toole S, Bartlett D The relationship between dentine hypersensitivity, dietary acid intake and erosive tooth wear. J Dent 2017;67:84-7.
Lee SY, Kwon HK, Kim BI Effect of dentinal tubule occlusion by dentifrice containing nano-carbonate apatite. J Oral Rehabil 2008;35:847-53.
Roveri N, Battistella E, Foltran I, Foresti E, Iafisco M, Lelli M, et al
. Synthetic biomimetic carbonate-hydroxyapatite nanocrystals for enamel remineralization. in Advanced Materials Research 2008;47: 821-824.
Norberto R, Elisa B, Claudia LB, Ismaela F, Elisabetta F, Michele I, et al
. Surface enamel remineralization: Biomimetic apatite nanocrystals and fluoride ions different effects. J Nanomaterials 2009;2009:8.
Orsini G, Procaccini M, Manzoli L, Giuliodori F, Lorenzini A, Putignano A A double-blind randomized-controlled trial comparing the desensitizing efficacy of a new dentifrice containing carbonate/hydroxyapatite nanocrystals and a sodium fluoride/potassium nitrate dentifrice. J Clin Periodontol 2010;37:510-7.
Schiff T, Saletta L, Baker RA, Winston JL, He T Desensitizing effect of a stabilized stannous fluoride/sodium hexametaphosphate dentifrice. Compend Contin Educ Dent 2005;26:35-40.
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al
. Consolidated Standards of Reporting Trials Group. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010;63:e1-37.
de Melo Alencar C, de Paula BLF, Guanipa Ortiz MI, Baraúna Magno M, Martins Silva C, Cople Maia L Clinical efficacy of nano-hydroxyapatite in dentin hypersensitivity: A systematic review and meta-analysis. J Dent 2019;82:11-21.
Poggio C, Lombardini M, Colombo M, Bianchi S Impact of two toothpastes on repairing enamel erosion produced by a soft drink: An AFM in vitro
study. J Dent 2010;38:868-74.
Anand S, Rejula F, Sam JVG, Christaline R, Nair MG, Dinakaran S Comparative evaluation of effect of nano-hydroxyapatite and 8% arginine containing toothpastes in managing dentin hypersensitivity: Double blind randomized clinical trial. Acta Medica (Hradec Kralove) 2017;60:114-9.
Orsini G, Procaccini M, Manzoli L, Sparabombe S, Tiriduzzi P, Bambini F, et al
. A 3-day randomized clinical trial to investigate the desensitizing properties of three dentifrices. J Periodontol 2013;84:e65-73.
Young S, Mason S, Milleman JL, Milleman KR A randomized clinical study to evaluate the effect of an ultra-low abrasivity dentifrice on extrinsic dental stain. Am J Dent 2017;30:255-61.
Ayad F, Ayad N, Vazquez J, Zhang YP, Mateo LR, Cummins D Use of a toothpaste containing 8% arginine and calcium carbonate for immediate and lasting relief of dentin hypersensitivity: A simple and effective in-office procedure. Am J Dent 2018;31:135-40.
Verma S, Boppana N, Valleri U, George A, Shetty MS Comparison of the efficacy of two different desensitizing agents: A randomized controlled trial. J Int Acad Periodontol 2017;19:22-7.
Alessandri Bonetti G, Pazzi E, Zanarini M, Marchionni S, Checchi L The effect of zinc-carbonate hydroxyapatite versus fluoride on enamel surfaces after interproximal reduction. Scanning 2014;36:356-61.
Caldeira EM, Fidalgo TK, Passalini P, Marquezan M, Maia LC, Nojima Mda C Effect of fluoride on tooth erosion around orthodontic brackets. Braz Dent J 2012;23:581-5.
Zanarini M, Pazzi E, Bonetti S, Ruggeri O, Alessandri Bonetti G, Prati C In vitro
evaluation of the effects of a fluoride-releasing composite on enamel demineralization around brackets. Prog Orthod 2012;13:10-6.
Poggio C, Gulino C, Mirando M, Colombo M, Pietrocola G Protective effect of zinc-hydroxyapatite toothpastes on enamel erosion: An in vitro
study. J Clin Exp Dent 2017;9:e118-22.
Jena A, Kala S, Shashirekha G Comparing the effectiveness of four desensitizing toothpastes on dentinal tubule occlusion: A scanning electron microscope analysis. J Conserv Dent 2017;20:269-72.
Vano M, Derchi G, Barone A, Pinna R, Usai P, Covani U Reducing dentine hypersensitivity with nano-hydroxyapatite toothpaste: A double-blind randomized controlled trial. Clin Oral Investig 2018;22:313-20.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]
| Article Access Statistics|
| Viewed||179 |
| Printed||14 |
| Emailed||0 |
| PDF Downloaded||55 |
| Comments ||[Add] |